Crestwood Advisors Group LLC Has $228,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Crestwood Advisors Group LLC reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,839 shares of the pharmacy operator’s stock after selling 1,995 shares during the period. Crestwood Advisors Group LLC’s holdings in Walgreens Boots Alliance were worth $228,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in WBA. Iron Horse Wealth Management LLC raised its position in Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares in the last quarter. Pineridge Advisors LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Blue Trust Inc. raised its position in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $30,000. Finally, Continuum Advisory LLC increased its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $8.97 on Wednesday. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average price of $11.03 and a two-hundred day moving average price of $15.83. Walgreens Boots Alliance, Inc. has a 1-year low of $8.90 and a 1-year high of $27.05. The company has a market cap of $7.74 billion, a P/E ratio of -1.33, a PEG ratio of 0.65 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the previous year, the business posted $1.00 earnings per share. The business’s revenue was up 2.8% on a year-over-year basis. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be paid a $0.25 dividend. The ex-dividend date is Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 11.15%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on WBA shares. JPMorgan Chase & Co. lowered their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Royal Bank of Canada lowered their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a report on Tuesday, July 2nd. Barclays lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Finally, Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a report on Friday, June 28th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $15.46.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.